Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$216M |
| 2 |
Charter Communications
CHTR
|
+$192M |
| 3 |
SLB Ltd
SLB
|
+$79.3M |
| 4 |
IBM
IBM
|
+$70.2M |
| 5 |
Newell Brands
NWL
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AFFX
Affymetrix Inc
AFFX
|
+$7.53B |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$447M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$229M |
| 4 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$208M |
| 5 |
SANDISK CORP
SNDK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.87% |
| 2 | Technology | 14.38% |
| 3 | Financials | 13.98% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RBPAA
3826
DELISTED
Royal Bancshares Of Pennsylvania Inc
RBPAA
| $57K | ﹤0.01% |
25,466
| – | – |
2013 Q2
12 quarters
|
|
3827
DELISTED
QLT Inc
QLTI
| $57K | ﹤0.01% |
40,811
+14,044
| +52% | +$21.6K |
2014 Q3
7 quarters
|
|
3828
IAMGOLD
IAG
$10.2B
| $56K | ﹤0.01% |
+13,795
| New | +$47K |
2016 Q2
0 quarters
|
|
|
KGJI
3829
DELISTED
Kingold Jewelry Inc.
KGJI
| $56K | ﹤0.01% |
5,218
| – | – |
2015 Q3
3 quarters
|
|
3830
ArcelorMittal
MT
$47.2B
| $55K | ﹤0.01% |
+3,991
| New | +$60.6K |
2016 Q2
0 quarters
|
|
3831
Perion Network
PERI
$345M
| $55K | ﹤0.01% |
15,858
-486
| -3% | -$2.11K |
2014 Q1
9 quarters
|
|
3832
Riley Exploration Permian
REPX
$1.07B
| $55K | ﹤0.01% |
6,190
| – | – |
2013 Q2
12 quarters
|
|
|
DXTR
3833
DELISTED
Dextera Surgical Inc.
DXTR
| $55K | ﹤0.01% |
+30,873
| New | +$63.2K |
2016 Q2
0 quarters
|
|
3834
LiqTech
LIQT
$12.4M
| $54K | ﹤0.01% |
2,830
| – | – |
2014 Q1
9 quarters
|
|
|
BIOC
3835
DELISTED
Biocept, Inc.
BIOC
| $54K | ﹤0.01% |
3
| – | – |
2015 Q1
5 quarters
|
|
3836
Insight Molecular Diagnostics
IMDX
$98.2M
| $53K | ﹤0.01% |
748
-139
| -16% | -$13K |
2016 Q1
1 quarter
|
|
3837
Sonoma Pharmaceuticals
SNOA
$5.41M
| $53K | ﹤0.01% |
75
| – | – |
2014 Q1
9 quarters
|
|
3838
ProQR Therapeutics
PRQR
$191M
| $52K | ﹤0.01% |
+10,939
| New | +$56.3K |
2016 Q2
0 quarters
|
|
3839
Riot Platforms
RIOT
$5.18B
| $52K | ﹤0.01% |
15,089
+1
| +0% | +$3 |
2013 Q2
12 quarters
|
|
|
EVEP
3840
DELISTED
EV Energy Partners, L.P.
EVEP
| $52K | ﹤0.01% |
23,010
-3,872
| -14% | -$9.42K |
2013 Q2
12 quarters
|
|
3841
DELISTED
Cogentix Medical, Inc.
CGNT
| $52K | ﹤0.01% |
55,091
| – | – |
2015 Q3
3 quarters
|
|
3842
Jaguar Health
JAGX
$7.08M
| – | – |
0
| – | – |
2015 Q3
3 quarters
|
|
3843
Pluri
PLUR
$11.7M
| $51K | ﹤0.01% |
485
| – | – |
2014 Q3
7 quarters
|
|
|
HTGM
3844
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $51K | ﹤0.01% |
110
| – | – |
2015 Q3
3 quarters
|
|
3845
Camtek
CAMT
$5.92B
| $50K | ﹤0.01% |
24,073
| – | – |
2015 Q1
5 quarters
|
|
3846
Paramount Gold Nevada
PZG
$90.5M
| $50K | ﹤0.01% |
30,702
| – | – |
2015 Q3
3 quarters
|
|
3847
DELISTED
Charles & Colvard Ltd
CTHR
| $50K | ﹤0.01% |
4,919
| – | – |
2013 Q2
12 quarters
|
|
|
MCEP
3848
DELISTED
Mid-Con Energy Partners, LP
MCEP
| $50K | ﹤0.01% |
+1,332
| New | +$73.4K |
2016 Q2
0 quarters
|
|
3849
DELISTED
Luna Innovations Incorporated
LUNA
| $50K | ﹤0.01% |
41,071
| – | – |
2013 Q2
12 quarters
|
|
3850
DELISTED
Presbia PLC Ordinary Shares
LENS
| $50K | ﹤0.01% |
11,158
| – | – |
2015 Q2
4 quarters
|
|
Similar funds
Geode Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, down 2.4% from $188B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management withdrew a net $8.49B in Q2 2016, closing 127 positions and reducing 984 holdings. Its most notable exit was Affymetrix Inc, an estimated $7.53B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Geode Capital Management opened a new position in S&P Global worth $215M.
- Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
- Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
- Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
- Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53B.
- Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
- Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
- Geode Capital Management's portfolio value fell 2.4% quarter-over-quarter to $184B.
Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.